Key facts
- This page summarizes Timothy Eugene Sullivan's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jan 2025, 12:15.
Timothy Eugene Sullivan - 29 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- APLS
- Reported as of
- 29 Jan 2025
- Net transaction value
- -$16,120
- SEC form
- 4
- Accepted by SEC
- 30 Jan 2025, 12:15:46 UTC
- Prior SEC filing
- 23 Jan 2025
- Next SEC filing
- 11 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/s David Watson, attorney-in-fact for Timothy Sullivan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy Eugene Sullivan filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 30 Jan 2025.
Change
- Previous filing in this sequence was filed on 23 Jan 2025.
- Current net transaction value: -$16,120.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Sale
- Transaction value
- $16,120
- Shares
- -546
- Change %
- -0.42%
- Price
- $29.52
- Shares after
- 128,665
- Date
- 29 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
APLS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 70,396
- Date
- 29 Jan 2025
- Ownership
- The Timothy E Sullivan Irrevocable Trust of 2023
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.
Footnote F2
The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.